The molecule also validated GLP-1 drugs at a commercial scale that helped define the market now contested by Lillys tirzepatide, a dual GIP/GLP-1 receptor agonist
If skin symptoms appeared or worsened following dose escalation, discussing with the prescribing provider whether to maintain the current dose longer before further titration, or whether a temporary dose reduction might be appropriate, could be considered
In a 2024 study, The study authors also found that semaglutide was an effective weight loss treatment regardless of sex, race, body size, or region
If youre looking for compounded semaglutide, find a reputable U.S.-based compounding pharmacy or standard pharmacy that offers compounding services and is registered with the FDA
Supplement products that can support weight loss are available at the retailers 700-plus stores and online within dedicated Whole Heath Rx displays